Hepatitis C-Viremic Kidneys Increasingly Used for Transplant
HCV-viremic kidneys are increasingly being used for transplants and seem to have good one-year outcomes.
Transplantation
Lung and Heart Transplants From HCV-Infected Donors: Expert Roundtable
Further patient advocacy is needed to ensure that recipients of HCV-infected organs have access to direct-acting antivirals as early as possible, including in a prophylactic manner, if data continue to support its benefit.
Updated AST IDCOP Guidelines for Vaccination of Organ Transplant Recipients
Vaccination of solid organ transplant candidates and recipients remains a critical component of preventing infection related morbidity and mortality.
DAA Treatment Before Liver Transplantation May Improve Outcome
Treatment with DAAs before liver transplantation is associated with improved outcome and appears to be safe in patients with decompensated hepatitis C-related cirrhosis.
Heart, Lungs From Donor With Hepatitis C Can Be Transplanted Safely
Hearts and lungs from donors with hepatitis C viremia can be safely transplanted into patients without HCV.
Overview of Updated Nocardia Infections Guidelines
Nocardia infections have increased significantly, likely as a result of improved detection methods and an expanding immunocompromised population.
HBV, HCV Control Aids Kidney Transplant Outcomes
The outcomes of kidney transplants in patients with viral suppression are as good as those for kidney transplants in patients not infected with HCV or HBV.
HBV, HCV, and HIV Screening Results of Deceased Solid Organ Donors
Increased risk donors may be significantly more likely to be HCV- and HBV-positive compared with standard risk donors.
Prognostic Index for Post-Engraftment Invasive Fungal Disease Validated
First of its kind prognostic index predicts the occurrence of post-engraftment invasive fungal disease after allogeneic hematopoietic stem cell transplant.
Fecal Microbiota Transplantation and Vancomycin for Recurrent C difficile
The combination of vancomycin and fecal microbiota transplantation was found to be superior to fidaxomicin or vancomycin for patients with recurrent CDI.
-
Loading...
-
Loading...
Next post in Clostridioides Difficile
